Zymo Research Launches COVID-19 Sequencing Service for the Detection and Surveillance of Emerging SARS-CoV-2 Variants
PR88052
IRVINE, Calif., Feb. 11, 2021 /PRNewswire=KYODO JBN/--
-- Rapid reporting at high throughput enables detection of potential vaccine
escaping variant strains
Zymo Research announced today their COVID-19 Variant Sequencing Service (
). This new global service expands Zymo Research's end-to-end SARS-CoV-2
solutions that include sample collection, RNA extraction, and SARS-CoV-2
detection. Detecting mutations quickly helps prevent the spread of new viral
strain types and can provide an early warning of potential vaccine escape.
Photo -
https://mma.prnewswire.com/media/1437224/Zymo_COVID_19_Variant_Identification_Service_PR.jpg
Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg
Zymo Research, an Illumina-certified sequencing service provider, uses the
Illumina COVIDSeq(TM) NGS workflow. The end-to-end service includes the
necessary collection devices and automated extraction technology, with RNA
sequencing completed on Illumina platforms. Zymo Research's DNA/RNA Shield(TM)
(
) is used for the collection, transportation, and preservation of the samples.
The preservative inactivates the SARS-CoV-2 virus while stabilizing its RNA,
allowing safe room temperature transport for robust library prep and sequencing.
"Zymo Research continues to play a significant role in combating the COVID-19
pandemic," said Dr. Keith Booher, Leader of Zymo Research Services. "As the
SARS-CoV-2 virus mutates, we are committed to developing products and services
in our COVID-19 testing portfolio to assist local and federal government
laboratories and health organizations in identifying new coronavirus variants
of concern, including those recently emerging from the UK (B.1.1.7), South
Africa (B.1.351), and Brazil (P.1)."
The COVID-19 Variant Sequencing Service workflow consists of sample collection,
processing, sequencing, and reporting. COVID-positive samples are collected
from test centers and transported to Zymo Research and its affiliates for
processing. Automated RNA extraction from the collected samples is performed
using the KingFisher(TM) Flex robotics platform. Sequencing is carried out
using the Illumina sequencing-by-synthesis technology and then analyzed using
the hardware-accelerated DRAGEN(TM) COVIDSeq(TM) Analysis Pipeline. The final
report includes COVID-19 strain identification, genome sequencing coverage,
confirmed mutations, consensus genome, and raw sequence files.
For more information and pricing visit Zymo Research's website (
) or contact them via email at covid19requests@zymoresearch.com.
About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific
and diagnostics community with state-of-the-art molecular biology tools since
1994. "The Beauty of Science is to Make Things Simple" is their motto, which is
reflected in all of their products, from epigenetics to DNA/RNA purification
technologies. Historically recognized as the leader in epigenetics, Zymo
Research is breaking boundaries with novel solutions for sample collection,
microbiomic measurements, diagnostic devices, and NGS technologies that are
high quality and simple to use. Follow Zymo Research on Facebook
(https://c212.net/c/link/?t=0&l=en&o=3065290-1&h=3160788738&u=https%3A%2F%2Fwww.
facebook.com%2Fzymoresearch&a=Facebook ), LinkedIn (
), Twitter (
), and Instagram (
).
For more information about Zymo Research's COVID-19 products, check out the
following links:
Zymo Research Releases Free Software to Streamline COVID-19 Test Reporting (
)
Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit (
)
Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick
SARS-CoV-2 rRT-PCR Kit (
)
Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA(TM) Viral MagBead Kit
(
)
SOURCE: Zymo Research Corp.
CONTACT: Marketing Department
Zymo Research Corp.
+1-949.679.1190
marketing@zymoresearch.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
